1,000
Participants
Start Date
June 27, 2025
Primary Completion Date
January 31, 2029
Study Completion Date
March 31, 2029
Quantitative Myocardial Blood Flow Evaluation
The perfusion sequence will produce on-the-fly additional quantitative perfusion maps with segmental myocardial blood flow values.
Qualitative Myocardial Blood Flow Evaluation
The perfusion sequence will not produce additional quantitative perfusion maps.
Gadavist
Participants will receive Gadavist 0.05 mmol/kg dose for each stress and rest perfusion imaging (total dose of 0.1 mmol/kg).
Vasodilator
All participants will receive vasodilator (regadenoson or adenosine depending on local site practice).
Blood draw for the laboratory assessment
A single (7-10 ml tube) whole blood sample will be collected from each patient for processing of blood biomarkers.
RECRUITING
Brigham and Women's Hospital, Boston
Brigham and Women's Hospital
OTHER